CytoSorbents Corporation (CTSO)

[pharmeng]

This is terrible...

At this point, we need convincing clinical data, or we will continue to deal with "lumpiness" in sales.

It's great we finally have plans for a cardiac surgery trial, but what about sepsis. We are still basing everything on success stories. My next fear is that the dosing study results will not give us any more clear picture for cytosorb in sepsis. The new therapy website says it's completed and undergoing data analysis, but no announcement yet, so I doubt it is conclusive at this time.

I'm just hoping that there will be some positive news from the cardiac partner Q2, otherwise we are waiting till 2nd half.